Zhang Financial’s Jazz Pharmaceuticals JAZZ Stock Holding History

Zhang Financial’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$655K	Hold	2,720	–	–	0.02%	234
2026 Q1	$514K	Buy	+2,720	New	+$475K	0.02%	245

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Zhang Financial's JAZZ Position: Q2 2026 in Review

Zhang Financial held its Jazz Pharmaceuticals (JAZZ) position steady in Q2 2026 at 2,720 shares worth $655K. The position accounts for 0.02% of the portfolio, ranked #234.

Zhang Financial first reported a position in JAZZ in Q1 2026 and has held it in 2 quarters since. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

Zhang Financial held 2,720 shares of Jazz Pharmaceuticals worth $655K as of Q2 2026.
Zhang Financial left its Jazz Pharmaceuticals share count unchanged in Q2 2026.
Jazz Pharmaceuticals made up 0.02% of Zhang Financial's portfolio in Q2 2026, its #234 holding.
Zhang Financial first reported a position in Jazz Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Zhang Financial's 13F filing for Q2 2026, filed 30 Jul 2026.